Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Q32 Bio (QTTB) Short-term Investments (2017 - 2025)

Historic Short-term Investments for Q32 Bio (QTTB) over the last 9 years, with Q3 2025 value amounting to $19.9 million.

  • Q32 Bio's Short-term Investments changed N/A to $19.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.9 million, marking a year-over-year change of. This contributed to the annual value of $141.0 million for FY2022, which is 19698.26% up from last year.
  • As of Q3 2025, Q32 Bio's Short-term Investments stood at $19.9 million.
  • Q32 Bio's Short-term Investments' 5-year high stood at $157.9 million during Q3 2022, with a 5-year trough of $8.0 million in Q1 2022.
  • For the 5-year period, Q32 Bio's Short-term Investments averaged around $68.7 million, with its median value being $62.2 million (2023).
  • Its Short-term Investments has fluctuated over the past 5 years, first crashed by 9050.37% in 2022, then skyrocketed by 128231.03% in 2023.
  • Q32 Bio's Short-term Investments (Quarter) stood at $47.5 million in 2021, then surged by 196.98% to $141.0 million in 2022, then plummeted by 47.4% to $74.2 million in 2023, then crashed by 86.54% to $10.0 million in 2024, then skyrocketed by 99.33% to $19.9 million in 2025.
  • Its Short-term Investments stands at $19.9 million for Q3 2025, versus $10.0 million for Q2 2024 and $19.8 million for Q1 2024.